The phenomenon is expected to be greatly enhanced in real in vivo settings when the compounds are flowing in the bloodstream and extravasating through the tumor leaky vessels, binding to cells expressing P-selectin (Figure 4—figure supplement 1). This evidence concerns the gene SELP and neoplasm.